Garenoxacin Mesylate Hydrate

甲磺酸加雷沙星

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameGarenoxacin Mesylate Hydrate
Drug Alias Name加诺沙星garenoxacinum加雷沙星甲磺酸水合物garenoxacinoGarenoxacin mesilate +[15
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsAcute BronchitisOtitis MediaOtorhinolaryngologic Diseases +[9
Global Approved IndicationsAcute BronchitisOtitis MediaOtorhinolaryngologic Diseases +[9
Approved Indications in ChinaOtorhinolaryngologic DiseasesPneumoniaRespiratory Tract Infections
Original Approved Country/TerritoryJapan
Original Approved Date2007/07/31
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTaisho Toyama
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAcute BronchitisOtitis MediaOtorhinolaryngologic Diseases +[9
Inactive IndicationsN/A

Other Information

ATC CodeJ01MA19